Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

Poplin E, Feng Y, Berlin J, Rothenberg ML, Hochster H, Mitchell E, Alberts S, O'Dwyer P, Haller D, Catalano P, Cella D, Benson AB
J Clin Oncol. 2009 27 (23): 3778-85

PMID: 19581537 · PMCID: PMC2727286 · DOI:10.1200/JCO.2008.20.9007

MeSH Terms (18)

Adult Aged Antimetabolites, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Deoxycytidine Disease-Free Survival Drug Administration Schedule Female Humans Infusions, Intravenous Kaplan-Meier Estimate Male Middle Aged Organoplatinum Compounds Oxaliplatin Pancreatic Neoplasms Treatment Outcome United States

Connections (1)

This publication is referenced by other Labnodes entities: